Citations

Showing 10 of 108162 citations.

Successful treatment of IgG4‐related hypertrophic pachymeningitis with induction rituximab and dexamethasone followed by maintenance rituximab
Seegobin, Karan , Moustafa, Muhamad Alhaj , Gannon, Nicole, Keller, Katelyn , Hastings, Jacquelyn, Jiang, Liuyan , Moustafa, Muhamad Alhaj , Tun, Han W. , Gupta, Vivek

Mayo Clinic

Clinical Case Reports | January 27, 2021 | Volume: 9 | Issue: 3 | Pages: 1610-1614

10.1002/ccr3.3855 | PMID 33768900 Get It

AbstractIgG4‐related disease (IgG4RD) with intracranial involvement is rare. We report a 56‐year‐old male who had an excellent response to rituximab and dexamethasone after going undiagnosed for 5 years. After 3 years of rituximab maintenance, he has no evidence of disease on brain MRI.
Small-Bowel Lymphoma Mimicking Crohn Disease: A Case Series
Chugh, Rishika , Ginsburg, Philip, Kröner, Paul T. , Farraye, Francis A.

Mayo Clinic

Inflammatory Bowel Diseases | January 27, 2021 | Volume: 27 | Issue: 5 | Pages: e61-e62

10.1093/ibd/izaa358 | PMID 33501981 Get It

Immersion learning at an aphasia camp: Analysing student video reflections
Sather, Thomas , Homolka, Terah, Clark, Mary Beth, Sather, Thomas W, Hoepner, Jerry K.

Mayo Clinic

International Journal of Speech-Language Pathology | January 27, 2021 | Volume: 23 | Issue: 4 | Pages: 430-440

10.1080/17549507.2020.1844294 | PMID 33501863 Get It

A Hybrid Machine-Learning-Based Method for Analytic Representation of the Vocal Fold Edges during Connected Speech
Yousef, Ahmed M. , Deliyski, Dimitar D. , Zacharias, Stephanie R. C. , Alarcón, Alessandro de , Orlikoff, Robert F. , Naghibolhosseini, Maryam , Naghibolhosseini, Maryam

Mayo Clinic

Applied Sciences | January 27, 2021 | Volume: 11 | Issue: 3 | Pages: 1179

10.3390/app11031179 | PMID 33717604 Get It

Investigating the phonatory processes in connected speech from high-speed videoendoscopy (HSV) demands the accurate detection of the vocal fold edges during vibration. The present paper proposes a new spatio-temporal technique to automatically segment vocal fold edges in HSV data during running speech. The HSV data were recorded from a vocally normal adult during a reading of the “Rainbow Passage.” The introduced technique was based on an unsupervised machine-learning (ML) approach combined with an active contour modeling (ACM) technique (also known as a hybrid approach). The hybrid method was implemented to capture the edges of vocal folds on different HSV kymograms, extracted at various cross-sections of vocal folds during vibration. The k-means clustering method, an ML approach, was first applied to cluster the kymograms to identify the clustered glottal area and consequently provided an initialized contour for the ACM. The ACM algorithm was then used to precisely detect the glottal edges of the vibrating vocal folds. The developed algorithm was able to accurately track the vocal fold edges across frames with low computational cost and high robustness against image noise. This algorithm offers a fully automated tool for analyzing the vibratory features of vocal folds in connected speech.
Assessment of automated clinical trial recruitment and enrolment using patient-facing technology
Bardach, Naomi S. , Lam, Regina W., Jasik, Carolyn Bradner , Lam, Regina

Mayo Clinic

BMJ Health & Care Informatics | January 27, 2021 | Volume: 28 | Issue: 1 | Pages: e100076

10.1136/bmjhci-2019-100076 | PMID 33504589 Get It

Objective Interactive patient care systems (IPCS) at the bedside are becoming increasingly common, but evidence is limited as to their potential for innovative clinical trial implementation. The objective of this study was to test the hypothesis that the IPCS could feasibly be used to automate recruitment and enrolment for a clinical trial. Methods In medical-surgical units, we used the IPCS to randomise, recruit and consent eligible subjects. For participants not interacting with IPCS study materials within 48 hours, study staff-initiated recruitment in-person. Eligible study population included all caregivers and any patients >6 years old admitted to medical-surgical units and oncology units September 2015 to January 2016. Outcomes: randomisation assessed using between-group comparisons of patient characteristics; recruitment success assessed by rates of consent; paperless implementation using successful acquisition of electronic signature and email address. We used χ2 analysis to assess success of randomisation and recruitment. Results Randomisation was successful (n=1012 randomised, p>0.05 for all between-group comparisons). For the subset of eligible, randomised patients who were recruited, IPCS-only recruitment (consented: 2.4% of n=213) was less successful than in-person recruitment (61.4% of n=87 eligible recruited, p<0.001). For those consenting (n=61), 96.7% provided an electronic signature and 68.9% provided email addresses. Conclusions Our results suggest that as a tool at the bedside, the IPCS offers key efficiencies for study implementation, including randomisation and collecting e-consent and contact information, but does not offer recruitment efficiencies. Further research could assess the value that interactive technologies bring to recruitment when paired with in-person efforts, potentially focusing on more intensive user-interface testing for recruitment materials. Trial registration number NCT02491190.
Temporal Trends of Infective Endocarditis in Olmsted County, Minnesota, Between 1970 and 2018: A Population-Based Analysis
Lahr, Brian D. , Anavekar, Nandan S., Tleyjeh, Imad M, Wilson, Walter R. , Tleyjeh, Imad M. , Sohail, Muhammad R, Tleyjeh, Imad M , DeSimone, Daniel C. , Sohail, M. Rizwan , Baddour, Larry M.

Mayo Clinic

Open Forum Infectious Diseases | January 27, 2021 | Volume: 8 | Issue: 3 | Pages: No page available

10.1093/ofid/ofab038 | PMID 33728357 Get It

Abstract Background A population-based study of infective endocarditis (IE) in Olmsted County, Minnesota, provides a unique opportunity to define temporal and seasonal variations in IE incidence over an extended time period. Methods This was a population-based review of all adults (≥18 years) residing in Olmsted County, Minnesota, with definite or possible IE using the Rochester Epidemiology Project from January 1, 1970, through December 31, 2018. Poisson regression was used to characterize the trends in IE incidence; models were fitted with age, sex, calendar time, and season, allowing for nonlinearity and nonadditivity of their effects. Results Overall, 269 cases of IE were identified over a 49-year study period. The median age of IE cases was 67.2 years, and 33.8% were female. The overall age- and sex-adjusted incidence of IE was 7.9 cases per 100 000 person-years (95% CI, 7.0–8.9), with corresponding rates of 2.4, 2.4, 0.9, and 0.7 per 100 000 person-years for Staphylococcus aureus, viridans group streptococci (VGS), Enterococcus species, and coagulase-negative staphylococci IE, respectively. Temporal trends varied by age, sex, and season, but on average IE incidence increased over time (P = .021). Enterococcal IE increased the most (P = .018), while S. aureus IE appeared to increase but mostly in the winter months (P = .018). Between 1996 and 2018, the incidence of VGS IE was relatively stable, with no statistically significant difference in the trends before and after the 2007 AHA IE prevention guidelines. Conclusions Overall, IE incidence, and specifically enterococcal IE, increased over time, while S. aureus IE was seasonally dependent. There was no statistically significant difference in VGS IE incidence in the periods before and after publication of the 2007 AHA IE prevention guidelines.
Breaking down barriers to care: Understanding migraine knowledge gaps among women's healthcare providers
O’Brien, Hope L. , Singh, Rashmi B. Halker

Mayo Clinic

Headache: The Journal of Head and Face Pain | January 27, 2021 | Volume: 61 | Issue: 1 | Pages: 7-8

10.1111/head.14034 | PMID 33616914 Get It

Association Between Sex and Treatment Outcomes of Atrial Fibrillation Ablation Versus Drug Therapy
Russo, Andrea M. , Zeitler, Emily P. , Giczewska, Anna , Silverstein, A , Al‐Khalidi, Hussein R. , Cha, Yong‐Mei , Monahan, Kristi H. , Bahnson, Tristram D. , Mark, Daniel B. , Packer, Douglas L. , Poole, Jeanne E. , Investigators, For the CABANA, Silverstein, Adam P , Mark, Daniel B , Investigators, For the CABANA

Mayo Clinic

Circulation | January 27, 2021 | Volume: 143 | Issue: 7 | Pages: 661-672

10.1161/circulationaha.120.051558 | PMID 33499668 Get It

Background: Among patients with atrial fibrillation (AF), women are less likely to receive catheter ablation and may have more complications and less durable results. Most information about sex-specific differences after ablation comes from observational data. We prespecified an examination of outcomes by sex in the 2204-patient CABANA trial (Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation). Methods: CABANA randomized patients with AF age ≥65 years or <65 years with ≥1 risk factor for stroke to a strategy of catheter ablation with pulmonary vein isolation versus drug therapy with rate/rhythm control agents. The primary composite outcome was death, disabling stroke, serious bleeding, or cardiac arrest, and key secondary outcomes included AF recurrence. Results: CABANA randomized 819 (37%) women (ablation 413, drug 406) and 1385 men (ablation 695, drug 690). Compared with men, women were older (median age, 69 years versus 67 years for men), were more symptomatic (48% Canadian Cardiovascular Society AF Severity Class 3 or 4 versus 39% for men), had more symptomatic heart failure (42% with New York Heart Association Class ≥II versus 32% for men), and more often had a paroxysmal AF pattern at enrollment (50% versus 39% for men) ( P <0.0001 for all). Women were less likely to have ancillary (nonpulmonary vein) ablation procedures performed during the index procedure (55.7% versus 62.2% in men, P =0.043), and complications from treatment were infrequent in both sexes. For the primary outcome, the hazard ratio for those who underwent ablation versus drug therapy was 1.01 (95% CI, 0.62–1.65) in women and 0.73 (95% CI, 0.51–1.05) in men (interaction P value=0.299). The risk of recurrent AF was significantly reduced in patients undergoing ablation compared with those receiving drug therapy regardless of sex, but the effect was greater in men (hazard ratio, 0.64 [95% CI, 0.51–0.82] for women versus hazard ratio, 0.48 [95% CI, 0.40–0.58] for men; interaction P value=0.060). Conclusions: Clinically relevant treatment-related strategy differences in the primary and secondary clinical outcomes of CABANA were not seen between men and women, and there were no sex differences in adverse events. The CABANA trial results support catheter ablation as an effective treatment strategy for both women and men. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT00911508.
RDH10 and ATRA sensitize triple-negative breast cancer to taxane-based chemotherapy through regulation of PIN1
Grainger, Jordan, Zhang, Lingxin , Yu, Jia , Vedell, Peter T. , Wang, Liewei , Thompson, Kevin J. , Kalari, Krishna R. , Suman, Vera J. , Boughey, Judy C. , Goetz, Matthew P.

Mayo Clinic

No container title available | January 27, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-86064/v2 Get It

Abstract Background: With few targeted therapies available for triple-negative breast cancer (TNBC), there is a critical need to identify biomarkers that can predict chemotherapy-response. Copy number amplifications (CNAmps) have been implicated in tumorigenesis, progression, and treatment response. Previously, we performed a prospective neoadjuvant chemotherapy study (BEAUTY) and identified a 5 Mb CNAmp in TNBC patients associated with pathological complete response rates to taxane- and anthracycline-based chemotherapy. Here we further interrogated this amplicon and its role in chemotherapy response. Methods: Using siRNA screening of genes identified in the 5 Mb CNAmp, followed by cytotoxicity assays, we identified RDH10 significantly associated with chemo-sensitivity in TNBC cell lines. Functional studies were performed using RDH10 knockdown or overexpression followed by cytotoxicity, cell proliferation, luciferase reporter assays, HPLC or western blot. Results: RDH10 is a rate-limiting step involved in the synthesis of all-trans retinoic acid (ATRA) - the active metabolite of retinoid metabolism that is frequently aberrant in cancer. Previous studies demonstrated ATRA to be a potent inhibitor of PIN1, a key regulator of several oncogenic signaling pathways often amplified in TNBC. We discovered that genetic manipulation of RDH10 affected ATRA intracellular concentrations, contributing to PIN1 degradation and taxane-response. Furthermore, co-treatment of TNBC cells with ATRA significantly increased taxane-sensitivity. Conclusion: RDH10 amplification increases endogenous levels of ATRA and degrades PIN1 in TNBC. ATRA-mediated degradation of PIN1 sensitizes TNBC to chemotherapy, suggesting that RDH10 may be a novel biomarker of taxane response and the addition of ATRA to standard chemotherapy may improve chemo-sensitivity.
Technical success and safety of peripherally inserted central catheters in the great saphenous and anterior accessory great saphenous veins
Jin, Mauricio F. , Comstock, Ann C, Levy, Emily R. , Reisenauer, Christopher J., McPhail, Ian R., Takahashi, Edwin A. , Levy, Emily R , Takahashi, Edwin A , Thompson, Scott M.

Mayo Clinic

The Journal of Vascular Access | January 27, 2021 | Volume: 23 | Issue: 2 | Pages: 280-285

10.1177/1129729821989166 | PMID 33499716 Get It

Background: Peripherally inserted central catheters (PICC) are occasionally placed in the great saphenous vein (GSV) and anterior accessory great saphenous vein (AAGSV) in patients with inadequate upper extremity veins or contraindications to upper extremity placement. Outcomes on the placement of PICCs in these veins are limited. Objectives: This study aimed to determine technical success and safety of GSV/AAGSV PICCs. Materials and methods: This is a retrospective study that reviewed all GSV/AAGSV PICC placements between January 2011 and December 2019. A total of 29 PICC placements procedures were identified. The electronic medical record was queried for demographic, procedural, and complication data. Technical success was defined by whether the vein could be accessed and a PICC could be placed. Catheter-associated infections, dislodgement or migration, malfunction, and PICC-associated thrombosis were recorded. Results: Technical success of placement was 100%. Twenty-one (72%) catheters were placed in the GSV in the mid to upper thigh and eight (28%) were placed in the AAGSV. The median PICC dwell time was 13 days with a range of 3–155 days. PICC-associated complications occurred after 11 (37.9%) placements. Line associated infection was the most common complication (17.2%). Conclusion: Due to a high complication rate, GSV/AAGSV PICC placement should be considered only when upper extremity or cervical PICC placement is not feasible or contraindicated.